G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,025,000 | -94.6% | 1,000 | -99.9% | 0.06% | -96.0% |
| Q4 2018 | $19,041,000 | -43.1% | 994,287 | +55.2% | 1.55% | -29.0% |
| Q3 2018 | $33,491,000 | +7.0% | 640,481 | -11.0% | 2.18% | -6.0% |
| Q2 2018 | $31,291,000 | +17.3% | 719,985 | 0.0% | 2.32% | +16.5% |
| Q1 2018 | $26,675,000 | +49.8% | 719,985 | -19.8% | 1.99% | +6.7% |
| Q4 2017 | $17,806,000 | -20.3% | 897,505 | 0.0% | 1.86% | -52.7% |
| Q3 2017 | $22,339,000 | +166.9% | 897,505 | +87.0% | 3.94% | +184.1% |
| Q2 2017 | $8,371,000 | – | 479,986 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |